Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | 8ef | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 1 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
TMT
|
|||||
| Competitor Name | Amine 8 | Competitor Info | ||||
| Competitor Concentration | 50 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Peripheral blood | ||||
| Disease Model | Acute myeloid leukemia [ICD-11:2A60] | |||||
| Model Name | Human acute myeloid leukemia cells (HL-60) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP14109 | FACT complex subunit SPT16 (SUPT16H) | 3.6 | ||||
Transcription factor
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP19380 | Zinc finger MYM-type protein 1 (ZMYM1) | 2.7 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP01074 | Bromodomain-containing protein 4 (BRD4) | 7.9 | ||||
| LDTP06304 | Bromodomain-containing protein 3 (BRD3) | 6.7 | ||||
| LDTP03322 | Bromodomain-containing protein 2 (BRD2) | 6.1 | ||||
